Skip to main content
Erschienen in: Journal of Community Health 6/2013

01.12.2013 | Original Paper

HPV Vaccination and Sexual Behavior in a Community College Sample

verfasst von: Erica Marchand, Beth A. Glenn, Roshan Bastani

Erschienen in: Journal of Community Health | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Many US parents are concerned that vaccinating daughters against human papillomavirus (HPV) will communicate implicit approval for sexual activity and be associated with early or risky sexual behavior (Scarinci et al. in J Womens Health 16(8):1224–1233, 2007; Schuler et al. in Sex Transm Infect 87:349–353, 2011) [7, 8]. The aims of this study were to understand (a) whether the HPV vaccine was associated with risky sexual behavior among a diverse sample of female adolescents and young adults, and (b) to better understand the chronology of HPV vaccination and sexual behavior. An anonymous web-based survey was used to collect data from 114 female community college students. T test and Chi square analyses were used to compare vaccinated and unvaccinated groups on age at first intercourse and proportion who had ever had sexual intercourse. Linear multiple regression was used to predict frequency of condom use and number of sexual partners in the past year, using vaccination status and demographic factors as predictors. About 38 % reported receiving at least one dose of the HPV vaccine. Many of those vaccinated (45 %) received the vaccine after having initiated sexual activity. The proportion of women who were sexually experienced did not differ by HPV vaccine status, nor did age at first intercourse, number of partners in the past year, or frequency of condom use. Current findings suggest that HPV vaccination is not associated with riskier sexual activity for the young women in this sample. Adolescents and their parents may benefit from education about the need to receive the HPV vaccine before onset of sexual activity.
Literatur
1.
Zurück zum Zitat Romanowski, B., de Borba, P. C., Naud, P. S., et al. (2009). Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: Analysis of a randomized placebo-controlled trial up to 6.4 years. Lancet, 374, 1975–1985.PubMedCrossRef Romanowski, B., de Borba, P. C., Naud, P. S., et al. (2009). Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: Analysis of a randomized placebo-controlled trial up to 6.4 years. Lancet, 374, 1975–1985.PubMedCrossRef
2.
Zurück zum Zitat Villa, L. L., Costa, R. L. R., Petta, C. A., et al. (2006). High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. British Journal of Cancer, 95, 1459–1466.PubMedCrossRef Villa, L. L., Costa, R. L. R., Petta, C. A., et al. (2006). High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. British Journal of Cancer, 95, 1459–1466.PubMedCrossRef
3.
Zurück zum Zitat CDC. (2011). Recommended adult immunization schedule: United States, 2011. MMWR, 60(4), 1–4. CDC. (2011). Recommended adult immunization schedule: United States, 2011. MMWR, 60(4), 1–4.
4.
Zurück zum Zitat CDC. (2011). Recommended immunization schedules for persons aged 0 through 18 years: United States, 2011. MMWR, 60(5), 1–4. CDC. (2011). Recommended immunization schedules for persons aged 0 through 18 years: United States, 2011. MMWR, 60(5), 1–4.
5.
Zurück zum Zitat CDC. (2013). Adult vaccination coverage: United States, 2011. MMWR, 62(4), 66–72. CDC. (2013). Adult vaccination coverage: United States, 2011. MMWR, 62(4), 66–72.
6.
Zurück zum Zitat CDC. (2012). National and state vaccination coverage among adolescents aged 13 through 17 years: United States, 2011. MMWR, 61(34), 671–677. CDC. (2012). National and state vaccination coverage among adolescents aged 13 through 17 years: United States, 2011. MMWR, 61(34), 671–677.
7.
Zurück zum Zitat Scarinci, I. C., Garcès-Palacio, I. C., & Partridge, E. E. (2007). An examination of acceptability of HPV vaccination among African American women and Latina immigrants. Journal of Women’s Health, 16(8), 1224–1233.PubMedCrossRef Scarinci, I. C., Garcès-Palacio, I. C., & Partridge, E. E. (2007). An examination of acceptability of HPV vaccination among African American women and Latina immigrants. Journal of Women’s Health, 16(8), 1224–1233.PubMedCrossRef
8.
Zurück zum Zitat Schuler, C. L., Reiter, P. L., Smith, J. S., et al. (2011). Human papillomavirus vaccine and behavioural disinhibition. Sexually Transmitted Infection, 87, 349–353.CrossRef Schuler, C. L., Reiter, P. L., Smith, J. S., et al. (2011). Human papillomavirus vaccine and behavioural disinhibition. Sexually Transmitted Infection, 87, 349–353.CrossRef
9.
Zurück zum Zitat Mullins, T. L. K., Zimet, G. D., Rosenthal, S. L., et al. (2012). Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Archives of Pediatric and Adolescent Medicine, 166, 82–88.CrossRef Mullins, T. L. K., Zimet, G. D., Rosenthal, S. L., et al. (2012). Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Archives of Pediatric and Adolescent Medicine, 166, 82–88.CrossRef
10.
Zurück zum Zitat Bednarczyk, R. A., Davis, R., Ault, K., Orenstein, W., & Omer, S. B. (2010). Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics, 130, 798–805.CrossRef Bednarczyk, R. A., Davis, R., Ault, K., Orenstein, W., & Omer, S. B. (2010). Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics, 130, 798–805.CrossRef
11.
Zurück zum Zitat Liddon, N. C., Leichliter, J. S., & Markowitz, L. E. (2012). Human papillomavirus vaccine and sexual behavior among adolescent and young women. American Journal of Preventive Medicine, 42, 44–52.PubMedCrossRef Liddon, N. C., Leichliter, J. S., & Markowitz, L. E. (2012). Human papillomavirus vaccine and sexual behavior among adolescent and young women. American Journal of Preventive Medicine, 42, 44–52.PubMedCrossRef
12.
Zurück zum Zitat Marchand, E., Glenn, B., & Bastani, R. (2012). Low HPV vaccine coverage among female community college students. Journal of Community Health, 37, 1136–1144.PubMedCrossRef Marchand, E., Glenn, B., & Bastani, R. (2012). Low HPV vaccine coverage among female community college students. Journal of Community Health, 37, 1136–1144.PubMedCrossRef
13.
Zurück zum Zitat Allen, J., Othus, M., Shelton, R. C., et al. (2010). Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers and Prevention, 19, 2187–2198.PubMedCrossRef Allen, J., Othus, M., Shelton, R. C., et al. (2010). Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers and Prevention, 19, 2187–2198.PubMedCrossRef
14.
Zurück zum Zitat Bastani, R., Glenn, B., Tsui, J., et al. (2011). Understanding sub-optimal HPV vaccine uptake among ethnic minority girls. Cancer Epidemiology, Biomarkers and Prevention, 20, 1463–1472.PubMedCrossRef Bastani, R., Glenn, B., Tsui, J., et al. (2011). Understanding sub-optimal HPV vaccine uptake among ethnic minority girls. Cancer Epidemiology, Biomarkers and Prevention, 20, 1463–1472.PubMedCrossRef
15.
Zurück zum Zitat Roberts, M., Gerrard, M., Reimer, R., & Gibbons, F. (2010). Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics, 125, 982–989.PubMedCrossRef Roberts, M., Gerrard, M., Reimer, R., & Gibbons, F. (2010). Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics, 125, 982–989.PubMedCrossRef
16.
Zurück zum Zitat Metzler, C. W., Noell, J., & Biglan, A. (1992). The validation of a construct of high-risk sexual behavior in heterosexual adolescents. Journal of Adolescent Research, 7, 233–249.CrossRef Metzler, C. W., Noell, J., & Biglan, A. (1992). The validation of a construct of high-risk sexual behavior in heterosexual adolescents. Journal of Adolescent Research, 7, 233–249.CrossRef
17.
Zurück zum Zitat Safran, D. G., Kosinski, M., Tarlov, A. R., et al. (1998). The primary care assessment survey: Tests of data quality and measurement performance. Medical Care, 36, 728–739.PubMedCrossRef Safran, D. G., Kosinski, M., Tarlov, A. R., et al. (1998). The primary care assessment survey: Tests of data quality and measurement performance. Medical Care, 36, 728–739.PubMedCrossRef
18.
Zurück zum Zitat Veldhuijze, N. J., Snijders, P. J. F., Reiss, P., Meijer, C. J. L. M., & van de Wijgert, J. H. H. M. (2010). Factors affecting transmission of mucosal human papillomavirus. Lancet Infectious Disease, 10, 862–874.CrossRef Veldhuijze, N. J., Snijders, P. J. F., Reiss, P., Meijer, C. J. L. M., & van de Wijgert, J. H. H. M. (2010). Factors affecting transmission of mucosal human papillomavirus. Lancet Infectious Disease, 10, 862–874.CrossRef
19.
Zurück zum Zitat Forhan, S. E., Gottlieb, S. L., Sternberg, M. R., et al. (2009). Prevalence of sexually transmitted infections among female adolescents aged 14–19 in the United States. Pediatrics, 124, 1505–1512.PubMedCrossRef Forhan, S. E., Gottlieb, S. L., Sternberg, M. R., et al. (2009). Prevalence of sexually transmitted infections among female adolescents aged 14–19 in the United States. Pediatrics, 124, 1505–1512.PubMedCrossRef
20.
Zurück zum Zitat Stupiansky, N. W., Zimet, G. D., Cummings, T., Fortenberry, J. D., & Shew, M. (2012). Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. Journal of Adolescent Health, 50, 103–105.PubMedCrossRef Stupiansky, N. W., Zimet, G. D., Cummings, T., Fortenberry, J. D., & Shew, M. (2012). Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. Journal of Adolescent Health, 50, 103–105.PubMedCrossRef
Metadaten
Titel
HPV Vaccination and Sexual Behavior in a Community College Sample
verfasst von
Erica Marchand
Beth A. Glenn
Roshan Bastani
Publikationsdatum
01.12.2013
Verlag
Springer US
Erschienen in
Journal of Community Health / Ausgabe 6/2013
Print ISSN: 0094-5145
Elektronische ISSN: 1573-3610
DOI
https://doi.org/10.1007/s10900-013-9710-0

Weitere Artikel der Ausgabe 6/2013

Journal of Community Health 6/2013 Zur Ausgabe